What is HealthEquity's stock symbol?
HealthEquity trades on the NASDAQ under the ticker symbol "HQY."
Where is HealthEquity's stock going? Where will HealthEquity's stock price be in 2017?
10 equities research analysts have issued 12-month target prices for HealthEquity's stock. Their forecasts range from $27.00 to $60.00. On average, they expect HealthEquity's share price to reach $40.33 in the next year.
When will HealthEquity announce their earnings?
HealthEquity is scheduled to release their next quarterly earnings announcement on Monday, March, 20th 2017.
What are analysts saying about HealthEquity stock?
Here are some recent quotes from research analysts about HealthEquity stock:
According to Zacks Investment Research, "HealthEquity, Inc. is a technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions. The Company's platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives, and make educated investment choices to grow their tax-advantaged healthcare savings. HealthEquity, Inc. is headquartered in Draper, Utah. " (2/13/2017)
- Chardan Capital analysts commented, "We are more confident in our estimates for HealthEquity (HQY) after a Chardan Leadership Investor Call that we hosted with HealthEquity Management on Thur. Feb. 9. Management team members Jon Kessler, CEO, and Darcy Mott, CFO struck a positive tone about market demand for HSAs and the regulatory environment. They also spoke to changes in their inorganic growth potential in the short to medium term." (2/13/2017)
Who owns HealthEquity stock?
HealthEquity's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Berkley W R Corp (16.45%), Janus Capital Management LLC (3.72%), FMR LLC (2.10%), State Street Corp (1.64%), Loomis Sayles & Co. L P (1.34%) and Franklin Resources Inc. (1.09%). Company insiders that own HealthEquity stock include Ashley Dreier, Berkley Capital Investors, LP, Darcy G Mott, Frank Corvino, Frank Medici, Ian Sacks, Jon Kessler, Jon Soldan, Manu S Rana, Matthew Sydney, Michael O Leavitt and Stephen Neeleman.
Who sold HealthEquity stock? Who is selling HealthEquity stock?
HealthEquity's stock was sold by a variety of institutional investors in the last quarter, including Berkley W R Corp, Janus Capital Management LLC, Thornburg Investment Management Inc., Oberweis Asset Management Inc., Royce & Associates LP, Franklin Resources Inc., Turner Investments LLC and Frontier Wealth Management LLC. Company insiders that have sold HealthEquity stock in the last year include Ashley Dreier, Darcy G Mott, Frank Corvino, Frank Medici, Ian Sacks, Jon Kessler, Jon Soldan, Manu S Rana, Matthew Sydney, Michael O Leavitt and Stephen Neeleman.
Who bought HealthEquity stock? Who is buying HealthEquity stock?
HealthEquity's stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Loomis Sayles & Co. L P, Cortina Asset Management LLC, Two Sigma Investments LP, State Street Corp, Silvercrest Asset Management Group LLC, Artisan Partners Limited Partnership and Elkfork Partners LLC.
How do I buy HealthEquity stock?
Shares of HealthEquity can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of HealthEquity stock cost?
One share of HealthEquity stock can currently be purchased for approximately $42.19.